Not applicableStudy completedNCT03975621What this trial is testingNurse AMIE: Addressing Metastatic Individuals EverydayWho this might be right forMetastatic Breast Cancer Milton S. Hershey Medical Center 21
Large-scale testing (Phase 3)Active Not RecruitingNCT02246621What this trial is testingNonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast CancerWho this might be right forBreast Cancer Eli Lilly and Company 493
Testing effectiveness (Phase 2)Study completedNCT00194714What this trial is testingVaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving TrastuzumabWho this might be right forHER2/Neu PositiveHLA-A2 Positive Cells PresentStage IV Breast Cancer+1 more University of Washington 22
Testing effectiveness (Phase 2)Study completedNCT00005963What this trial is testingDocetaxel and Carboplatin in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 53
Not applicableStudy completedNCT04756921What this trial is testing18F-FDG Uptake Heterogeneity Predicts Pyrotinib ResponseWho this might be right forHER2-positive Breast Cancer Biyun Wang, MD 30
Not applicableStudy completedNCT01199393What this trial is testingGenetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast CancerWho this might be right forBreast NeoplasmDrug TherapyPolymorphism,Single Nucleotide Peking University Cancer Hospital & Institute 153
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Testing effectiveness (Phase 2)Study completedNCT00005798What this trial is testingCombination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast CancerWho this might be right forBreast Cancer H. Lee Moffitt Cancer Center and Research Institute 209
Large-scale testing (Phase 3)Ended earlyNCT04395339What this trial is testingGM1 Prophylaxis for WBRT Related Cognitive DysfunctionWho this might be right forBrain MetastasesRadiotherapy Side EffectCognitive Impairment+2 more Sun Yat-sen University 51
Not applicableStudy completedNCT05458401What this trial is testingEUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab DeruxtecanWho this might be right forHER2-positive Breast Cancer Daiichi Sankyo 256
Testing effectiveness (Phase 2)Study completedNCT00234403What this trial is testingA Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer AstraZeneca 60
Large-scale testing (Phase 3)Looking for participantsNCT05646862What this trial is testingA Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination TherapyWho this might be right forBreast Cancer Hoffmann-La Roche 420
Testing effectiveness (Phase 2)Study completedNCT00368875What this trial is testingPhase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast CancerWho this might be right forMale Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+1 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)UnknownNCT04742153What this trial is testingMRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC)Who this might be right forAdvanced or Metastatic Breast Cancer Shanghai Miracogen Inc. 66
Testing effectiveness (Phase 2)Study completedNCT01019577What this trial is testingClinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane ResistantWho this might be right forMetastatic Breast Cancer R-Pharm 54
Early research (Phase 1)Ended earlyNCT03429101What this trial is testingPoziotinib in Combination With T-DM1 in HER2-Positive Breast CancerWho this might be right forBreast Cancer Spectrum Pharmaceuticals, Inc 6
Testing effectiveness (Phase 2)Looking for participantsNCT04923542What this trial is testingSRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain MetastasesWho this might be right forBrain MetastasesHR+ Metastatic Breast Cancer H. Lee Moffitt Cancer Center and Research Institute 31
Testing effectiveness (Phase 2)Looking for participantsNCT07011654What this trial is testingStudy of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)Who this might be right forMetastatic Triple-Negative Breast Cancer M.D. Anderson Cancer Center 31
Post-approval studies (Phase 4)UnknownNCT05131841What this trial is testingCipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBCWho this might be right forMetastatic Breast Cancer Zhejiang Cancer Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04538742What this trial is testingA Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer AstraZeneca 245